Monthly Archives: January 2008

Featured Stories

FDA Gives 7 Companies Go Ahead To Market Generic Plavix

The U.S. Food & Drug Administration (FDA) just gave seven companies the go-ahead to market generic Plavix. Plavix is a blood thinner prescribed for the prevention of blood clots, heart attacks, and which has been linked to serious side effects such as the heart attacks and strokes it is supposed to ...

Read More

Study Suggests Hormonal Contraceptives Linked to Brain Tumor

Study Suggests Hormonal Contraceptives Linked to Increased Brain Tumor Risk

A study of Danish women of reproductive age suggests that long-term use of hormonal contraceptives is associated with an increased risk of brain tumors.

Read More

64 More Plavix Patients File Suit Over Bleeding Side Effects

Another Plavix lawsuit has been filed on behalf of 64 Plavix patients who allege bleeding side effects. Plavix (clopidogrel) is a blood thinner prescribed for the prevention of blood clots and heart attacks, and has been linked to serious side effects, such as the heart attacks and strokes it is ...

Read More

Toxic Nano-Particles from Failing Metal-on-Metal Hip Replacements May Pose Long-Term Health Risks

According to a new study, failing metal-on-metal hip implants generate toxic nano-particles that release Cobalt 2+ ions, which not only cause inflammation in surrounding tissue, but have the potential to cause long-term damage to the genetic material of cells. According to a report published by Medicalxpress.com, this “genotoxicity” could ...

Read More

What Action Will the FDA Take on E-cigarettes?

What Action Will the FDA Take on E-cigarettes?

As health and quality concerns trouble the e-cigarette industry, experts and the public await the Food and Drug Administration (FDA)’s action to regulate the devices.

Read More

Majority of Metal-on-Metal Hip Implant Failures Occur within Two Years, Study Finds

A newly published metal-on-metal hip replacement study is reporting that the majority of failures occur early, within two years of surgery. The study, published in the journal Orthopedics, is just the latest to indicate that close follow-up of metal-on-metal hip implant patients is warranted.

Read More

Older Patients Face Heart Attack Risk Following Surgery

Older Hip Implant, Knee Replacement Patients Face Heart Attack Risk Following Surgery

An emerging report reveals that older hip implant and knee replacement patients face increased heart attack risks following surgery. The risk for acute myocardial infarction (AMI) was seen in the first two weeks after these surgical procedures.

Read More

Medtronic Infuse Lawsuit Alleges Off-Label Use Cause Painful Complications

A man in Louisiana has filed suit against Medtronic Inc. over injuries allegedly cause by off-label use of its Infuse Bone Graft product. The plaintiff, who received Infuse during transforaminal spinal lumbar fusion surgery, claims that the bone growth protein caused unwanted bone growth along his spine, worsening the back ...

Read More

EMA Seeks Stronger Pradaxa Guidance for Bleeding Side Effects

Regulators in Europe have again asked Boehringer Ingelheim, the manufacturer of the blood thinner Pradaxa, to update the drug’s label with additional information regarding Pradaxa bleeding side effects. According to the European Medicines Agency (EMA), the new guidance should include more specific information on when Pradaxa must not be used, ...

Read More

Metal-on-Metal Hip Replacement Device

Smith & Nephew’s Birmingham Metal-on-Metal Hip Replacement Device

Wright Medical Inc. took steps in to 2006 to convince the U.S. Food & Drug Administration (FDA) to reject pre-market approval of rival Smith & Nephew’s Birmingham metal-on-metal hip implant. Wright Medical, which makes two metal-on-metal hip replacement devices, the Conserve and the Lieneage device, filed a citizen petition ...

Read More

Head Lice Drugs Toxic, FDA Warns

Linade Shampoo and Lindane Lotion, two popular used to treat head lice can be toxic, the Food & Drug Administration (FDA) has warned.   Morton Grove Pharmaceuticals, which makes Lindane Shampoo and Lindane Lotion, is the only U.S. maker of an … Continue reading

Posted in Legal News, Pharmaceuticals |

NSF Study Finds Link between Gadolinium Used in MRI and Debilitating Disease

Another Nephrogenic Systemic Fibrosis (NSF) study has tied the debilitating condition to Gadolinium contrast agents used in Magnetic Resonance Imaging (MRI).  This latest NSF research was conducted by the Centers for Disease Control (CDC), which examined a cluster of NSF … Continue reading

Posted in Gadolinium, Legal News, Pharmaceuticals |

NuCel Eye Drops, Ear Wash Recalled over Contamination Concerns

NuCel-brand eye drops and eye-ear wash are subject to a voluntary, nationwide recall due to possible contamination, the U.S. Food and Drug Administration (FDA) announced today. According to the FDA, the NuCel products are not sterile. NuCel Labs of Idaho … Continue reading

Posted in Legal News, Pharmaceuticals |

US “Abortion Pill” Supplier Caught up in Chineses Tainted Drug Scandal, Leading to RU-486 Safety Concerns

The Chinese manufacturer of the so-called “abortion pill” is accused of selling tainted cancer drugs in that country.  Shanghai Hualian is the only supplier to the U.S. of the abortion pill, mifepristone—or RU-486.   It is one of China’s largest state-owned … Continue reading

Posted in Legal News, Pharmaceuticals |

Zyprexa Illegal Marketing Could Cost Eli Lilly $1 Billion+

< "http://www.yourlawyer.com/topics/overview/zyprexa">Zyprexa maker Eli Lilly is in negotiations with state and federal prosecutors that could result in the company paying more than $1 billion to settle charges that it engaged in illegal off-label marketing of Zyprexa. According to The Wall … Continue reading

Posted in Legal News, Pharmaceuticals |

Avandia Study Leaked by Glaxo-Paid Reviewer

The < "http://www.yourlawyer.com/topics/overview/avandia">Avandia study that touched off a firestorm over the diabetes drug’s cardiac side effects was leaked to GlaxoSmithKline ahead of its publication in the New England Journal of Medicine (NEJM).  According to a report in the Wall Street … Continue reading

Posted in Legal News, Pharmaceuticals |

Tonsillectomy Patients Often Burned by Defective Cauterizing Devices

< "http://www.yourlawyer.com/practice_areas/defective_medical_devices">Defective cauterizing devices used during tonsillectomy often burn areas around the lips and mouth. As it turns out, these cauterizing device burns are an underreported complication of tonsillectomy that can result in long-term problems, according to a study reported … Continue reading

Posted in Defective Medical Devices, Legal News |

Similar Drug Names Often Lead to Tragic Consequences

Like sounding drug names could be behind a spike in < "http://www.yourlawyer.com/practice_areas/defective_drugs">medication errors.  Shockingly, medication mix-ups have more than doubled in the past few years since 2004 and can have deadly consequences.  The prevailing issue seems to be the result … Continue reading

Posted in Legal News, Pharmaceuticals |

Botox to Undergo Canadian Safety Review

< "http://www.yourlawyer.com/practice_areas/defective_drugs">Botox death reports have prompted Canadian regulatory authorities to take another look at the drug.  Health Canada is looking at the safety information on Botox, which is approved in Canada to fight wrinkles as well as for non-cosmetic purposes, … Continue reading

Posted in Legal News, Pharmaceuticals |

Florida Vioxx Plaintiffs Look to Expand Settlement

< "http://www.yourlawyer.com/topics/overview/vioxx">Vioxx plaintiffs in Florida are petitioning a federal court to expand Merck’s proposed $4.85 billion settlement to include those who did not file suit against the company by Nov. 9, 2007.  But many lawyers involved in the Vioxx settlement … Continue reading

Posted in Class Action Lawsuits, Legal News, Pharmaceuticals, Vioxx, Vioxx |

© 2005-2017 Parker Waichman LLP ®. All Rights Reserved.